Small Cell Lung Cancer Clinical Trials

Muscle Shoals : Investigational Site Number 840007

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Tucson : Arizona Cancer Center @ UMC North

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Santa Monica : UCLA Oncology Center

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Westwood : UCLA Oncology Center

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Newark : Helen F. Graham Cancer Center

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Fort Lauderdale : Holy Cross Hospital

CALGB 30610

Fort Lauderdale : Holy Cross Hospital Updated

IMGN 901 NORTH

View More »

Fort Lauderdale : Holy Cross Hospital Bienes Comprehensive Cancer Center

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Gainesville : University of Florida

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Miami : VA. Medical Center

Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer

Elk Grove Village : Alexian Brothers Hospital Network

A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) - IIIA Non-Small Cell Lung Cancer (NSCLC).

Elk Grove Village : Alexian Brothers Hospital Network

E1508 A Randomized Phase II Study of Cisplatin and Etoposide In Combination with Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients with Extensive Stage Small Cell Lung Cancer

View More »

Chicago : Northwestern University Feinberg School of Medicine

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Bloomington : Cancer Care Center of Southern Indiana

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Evansville : Oncology Hematology Associates of SW Indiana

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Fort Wayne : Fort Wayne Oncology & Hematology, Inc

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Indianapolis : IN Onc/Hem Associates

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Indianapolis : St. Vincent Hospital & Health Centers

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

View More »

Indianapolis : Indiana University Simon Cancer Center

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Lafayette : Horizon Oncology Researcg

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Lafayette : IU Health Arnett Cancer Center

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Muncie : IU Health at Ball Memorial Hospital

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Munster : Monroe Medical Associates

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

South Bend : Northern Indiana Cancer Research Consortium

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Terre Haute : Providence Medical Group

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Baltimore : Johns Hopkins University

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Baltimore : University of Maryland Greenebaum Cancer Center

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Boston : Dana Farber Cancer Institute

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Boston : Massachusetts General Hospital

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Omaha : Investigational Site Number 840005

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Lebanon : Investigational Site Number 840006

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Hackensack : Johnson Therurer Cancer Center at Hackensack

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Hackensack : Hackensack University Medical Center

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Mt. Holly : Hematology Oncology Associates S.J., P.A.

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Durham : Duke University Medical Center

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Middletown : Investigational Site Number 840003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Oklahoma City : Oklahoma University

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Portland : Oregon Health and Science University

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Portland : Providence Portland Medical Center

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Philadelphia : Investigational Site Number 840001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Philadelphia : Investigational Site Number 840101

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Philadelphia : Pennsylvania Oncology-Hematology Associates

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Columbia : South Carolina Oncology Associates

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Nashville : Sarah Cannon Research Institute

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

San Antonio : UTHSC at San Antonio

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

San Antonio : South Texas Accelerated Research Therapeutics (START)

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Salt Lake City : Investigational Site Number 840004

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Brussels : University Clinic Saint-Luc

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Porto Alegre : Investigational Site Number 076001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Hamilton : Juravinski Cancer Center

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Montreal : St. Mary's Hospital

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Montreal : Jewish General Hospital

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Montreal : Montreal General Hospital

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Montreal : Investigational Site Number 124003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

View More »

Oshawa : Investigational Site Number 124002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Rimouski : Investigational Site Number 124004

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Toronto : Investigational Site Number 124001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Santiago : Investigational Site Number 152001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Santiago : Investigational Site Number 152003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Santiago : Investigational Site Number 152005

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Angers : Centre Hospitalier Universitaire

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Bastia : Site 05

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Beauvais : Site 22

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Brest : Investigational Site Number 250005

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Brest : Centre Hospitalier du Morvan

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

View More »

Caen : Centre François Baclesse

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Caen : Site 43

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Caen Cedex : Investigational Site Number 250004

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Cergy-pontoise : Centre Hospitalier René Dubos

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Creteil : Site 33

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Draguignan : Site 07

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Elbeuf : Site 32

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

GAP : Site 04

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

La Roche Sur Yon : Centre Hospitalier Les Oudairies

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

La Tronche : Investigational Site Number 250006

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Lille : Investigational Site Number 250002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Limoges : Hospital du Cluzeau

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Longjumeau : Centre Hospitalier Régional

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Lyon : Centre Hospitalier Lyon Sud

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Mantes La Jolie : Site 25

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Marseille : Site 06

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Martigues : Site 27

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Meaux : Site 01

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Paris : Hospital Saint Antoine

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Rouen : Site 17

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Saint Brieuc : Hôpital Yves Le Foll

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Saint-Herblain Cedex : Investigational Site Number 250003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Toulon : Site 14

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Toulouse : Investigational Site Number 250001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Villefranche Sur Saone : Site 11

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Villejuif Cedex : Investigational Site Number 250007

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Berlin : Hematology & Oncology Charité CBF Berlin, Germany

A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Großhansdorf : Investigational Site Number 276003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Kassel : Investigational Site Number 276001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Löwenstein : Investigational Site Number 276006

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Athens : Investigational Site Number 300003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Athens : Investigational Site Number 300005

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Heraklion : Investigational Site Number 300001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Thessaloniki : Investigational Site Number 300004

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Thessaloniki : Investigational Site Number 300002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Budapest : Investigational Site Number 348001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Budapest : Investigational Site Number 348002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Budapest : Investigational Site Number 348004

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Gyula : Investigational Site Number 348005

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Törökbálint : Investigational Site Number 348003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Genova : Investigational Site Number 380001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Livorno : Investigational Site Number 380002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Monza : Investigational Site Number 380003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Novara : Investigational Site Number 380005

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Parma : Investigational Site Number 380004

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Tokorozawa, Saitama : Department of Obstetrics and Gynecology, National Defense Medical College Hospital

An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors

Daegu : Chungbuk University Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Daegu : Keimyung University Dongsan Center

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Goyang : National Cancer Center.

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Goyang-si : National Cancer Center, Korea

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

Seoul : Investigational Site Number 410001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

View More »

Seoul : Investigational Site Number 410002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Seoul : Investigational Site Number 410003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Seoul : Seoul National University Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Seoul : Seoul St. Mary's Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Seoul : Severance Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Seoul : Asan Medical Center

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Suwon : Ajou University Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Suwon : St. Vincent's Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Oslo : Investigational Site Number 578001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Stavanger : Investigational Site Number 578003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Trondheim : Investigational Site Number 578002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Gdansk : Investigational Site Number 616004

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Lublin : Investigational Site Number 616003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Poznan : Investigational Site Number 616002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Warszawa : Investigational Site Number 616001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Cluj Napoca : Investigational Site Number 642003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Cluj-Napoca : Investigational Site Number 642005

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Craiova : Investigational Site Number 642001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Timisoara : Investigational Site Number 642002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Moscow : Investigational Site Number 643001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

St-Petersburg : Investigational Site Number 643005

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Tula : Investigational Site Number 643006

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Yaroslavl : Investigational Site Number 643003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Badalona : Investigational Site Number 724002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Barcelona : Hospital de la Santa Creu y Sand Pau

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Barcelona : Investigational Site Number 724004

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Madrid : Hospital Universitario 12 de Octubre

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Madrid : Hospital Universitario

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

View More »

Málaga : Investigational Site Number 724005

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Valencia : Investigational Site Number 724001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Valencia : Investigational Site Number 724003

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Gävle : Gävle hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Göteborg : Sahlgrenska University Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Helsingborg : Helsingborg Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Jönköping : Ryhov Hospital, Jönköping

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Karlskrona : Blekinge Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

View More »

Karlstad : Central Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Kristianstad : Central Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Linköping : University Hospital Linköping

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Lund : University Hospital Department of Respiratory Medicine

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Malmö : University Hospital MAS

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Örebro : University Hospital, Örebro

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Stockholm : Karolinska University Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Umeå : Norrlands University Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Uppsala : Akademiska hospital Uppsala

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Växjö : Central Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Ystad : Ystad hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Tainan City : National Cheng Kung University Hospital

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Taipei : National Taiwan University Hospital

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Taoyuan : Chang Gung Memorial Hospital - LinKou Branch

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Dnipropetrovsk : Investigational Site Number 804002

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Donetsk : Investigational Site Number 804004

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Lviv : Investigational Site Number 804001

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Brighton : Royal Sussex Hospital

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Cambridge : Cambridge University Hospitals NHS Foundation Trust

HYPAZ: Hypertension Induced by Pazopanib

Downs Road : Royal Marsden, Sutton

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

London : University College of London

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

London : Royal Marsden, London

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

View More »

Withington : The Christie Hospital

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer